Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 18, 2024

BUY
$235.51 - $267.98 $346,199 - $393,930
1,470 Added 29.88%
6,389 $1.6 Million
Q1 2024

May 03, 2024

SELL
$224.58 - $256.19 $11.7 Million - $13.3 Million
-51,947 Reduced 91.35%
4,919 $1.23 Million
Q4 2023

Feb 09, 2024

SELL
$185.1 - $233.13 $11,291 - $14,220
-61 Reduced 0.11%
56,866 $13.2 Million
Q3 2023

Oct 18, 2023

BUY
$233.08 - $265.59 $8.96 Million - $10.2 Million
38,433 Added 207.81%
56,927 $14.1 Million
Q2 2023

Jul 27, 2023

BUY
$224.99 - $256.14 $1.6 Million - $1.83 Million
7,131 Added 62.76%
18,494 $4.44 Million
Q1 2023

May 05, 2023

SELL
$239.75 - $277.0 $725,963 - $838,756
-3,028 Reduced 21.04%
11,363 $2.86 Million
Q4 2022

Feb 14, 2023

BUY
$241.42 - $282.29 $3.47 Million - $4.06 Million
14,391 New
14,391 $3.82 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $153B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Coronation Fund Managers Ltd. Portfolio

Follow Coronation Fund Managers Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Coronation Fund Managers Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Coronation Fund Managers Ltd. with notifications on news.